Search

everythinglearnresearchcommunity

for

Search:↓

A combination of methotrexate injections and CO2 laser treatment led to complete hair regrowth in two patients with hard-to-treat alopecia.

Intralesional chemotherapy with 5-fluorouracil and methotrexate may worsen keratoacanthoma-type skin cancer in transplant patients.

Cryotherapy and steroid injections are similarly effective and safe for treating alopecia areata.

Corticosteroid injections for hair loss may cause eye problems, so caution is needed.

Steroid injections are more effective than platelet rich plasma for treating patchy hair loss.

Intralesional triamcinolone acetonide is more effective but has a higher relapse rate than platelet-rich plasma for treating alopecia areata.

The patient's hair loss from alopecia totalis returned despite initial successful treatment.

Current treatments for alopecia show no significant long-term benefits.

There are no FDA-approved treatments for Alopecia Areata, and current options have varying success and relapse rates.

Some treatments can help with hair regrowth in alopecia areata, but results vary and long-term use is often needed without changing the disease's outcome.

Most treatments for lichen planopilaris were found to be generally unsatisfactory.

Some treatments like methotrexate with prednisone might help juvenile morphea, but more research is needed to confirm.

Tailored treatments for alopecia areata are recommended based on severity and patient needs.

Effective treatments for lichen planopilaris are unclear due to inconsistent results and a lack of strong research evidence.

Different treatments for alopecia areata have unpredictable results and varying success rates.

Some treatments can stabilize Frontal Fibrosing Alopecia, but more research is needed to find effective treatments, and hair transplants often fail.

A 9-year-old girl with alopecia areata had successful hair regrowth using bimatoprost after other treatments failed.

New treatments for Frontal Fibrosing Alopecia show promise, especially finasteride and dutasteride, with most patients seeing improvement or stabilization.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Current treatments for alopecia areata often fail to achieve and maintain significant hair regrowth.

Both treatments for localized alopecia areata are equally effective.

Some treatments that modify the immune system might help with certain types of hair loss but haven't been explored for common hair loss alone.

New treatments for sudden hair loss include oral medications and a special laser, both showing promise in hair regrowth.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Some new treatments for children's skin conditions are effective, but risks must be weighed.

More effective treatments are needed for severe alopecia areata.

Both steroid treatments effectively regrow hair in severe alopecia areata.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

The document concludes that better treatments for CCCA are needed and more research is required to understand its causes related to hairstyling and genetics.

PRP is popular in aesthetic treatments but its effectiveness and safety are still questioned.